Transparency data

Non-tech. summaries 2014: projects on the cardiovascular system

Projects granted during 2014 that have a primary purpose of basic research into the cardiovascular, blood and lymphatic system.


Non-technical summaries: projects granted in 2014, volume 19

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email Please tell us what format you need. It will help us if you say what assistive technology you use.


This document outlines the projects granted under the Animals (Scientific Procedures) Act 1986 during 2014 with a primary purpose of basic research into the cardiovascular, blood and lymphatic system.

The following projects were granted:

  • neural regulation of cardiovascular function (blood pressure, sympathetic, hypertension, homeostasis, autonomic nervous system)
  • neural control of myocardial excitability in cardiovascular disease (heart, brain, autonomic nervous system, free radical, cyclic nucleotides)
  • characterizing how lipids regulate cardiovascular disease and bleeding (atherosclerosis, lipids, bleeding)
  • therapeutic neovascularisation for ischemic disease (neovascularisation, Ischemia, cardiovascular disease)
  • molecular regulation of heart development (mouse, embryo, development, heart, vasculature)
  • prevention of organ injury following cardiac surgery (cardiac surgery, organ failure, transfusion)
  • interplay between oxygen and iron in hypoxia-induced pathology (iron, hypoxia, heart, muscle, placenta)
  • inflammation and atherosclerosis (inflammation, atherosclerosis, collar, disease, therapy)
  • provision of biological materials (blood, macaque, in-vitro)
  • thromboinflammation in thrombosis in veins (thrombosis, inflammation, mast cells, T-cells, platelets)
  • genetics of cardiovascular development and function (heart development, heart disease, genetics)
  • studies on the mechanisms of atherosclerosis (accelerated atherosclerosis, restenosis, hypercholesterolaemia)
  • regulation of haematopoietic development (Haematopoiesis, Angiogenesis, Embryogenesis, Leukaemia)
  • production of antibodies for research purposes (production of antibodies for research)
  • regulation of heart development in vertebrates (heart, cardiogenesis, morphology, non-compaction)
  • endothelial dysfunction in pulmonary hypertension (vessel wall thickening, lung, hypoxia, inflammation)
  • de novo generation of haematopoietic stem cells (blood, stem cells, genetic program, haematopoiesis, transplantation)
  • antibody production (antibodies, immunisation)
  • regulation of blood vessel maintenance and repair (blood vessels, heart attack, aneurysm, cardiovascular disease)
  • adaptive mechanisms of the ischaemic myocardium (myocardial infarction, gene-modified animals, redox, cardiac remodelling, heart failure)
  • characterising and inhibiting vascular disturbances (microcirculation, stem cells, inflammation)
  • regenerative capacity of skeletal and cardiac muscle (cardiac stem cells; skeletal muscle stem cells; repair, regeneration; myocardium)
  • regulation and mechanism of platelet activation by GPVI and CLEC-2 (platelets, signal-transduction, haemostasis, vascular-integrity)
  • cardiovascular effects of uraemia (kidney disease, heart failure, uraemia, diabetes)
  • systems biology of cardiac biophysics (heart rhythm, infarction, ablation, fibrosis)
  • the regulation and role of protein kinases in the heart (heart failure, the failing heart, heart disease, protein kinases, phosphorylation)
  • mouse models of cardiovascular development and disease (heart, cardiogenesis, CHD, mouse models 4)
  • control of early heart development in vertebrates (heart, embryo, frog)
  • molecular mechanisms of development (angiogenesis, inflammation, drug screening, molecular targets)
Published 25 April 2016